Google taps Geisinger CEO to oversee health efforts
As CEO David Feinberg heads to the tech giant, Geisinger executive vice president and CMO Jaewon Ryu will serve as the health system's interim president and CEO.
Andy Slavitt and AVIA oversee the Medicaid Transformation Project
A total of 17 health systems will take part in the effort, which is co-led by Slavitt, who was the acting administrator of CMS under the Obama administration, and AVIA, an innovation network for hospitals and health systems.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Geisinger’s latest work: An upcoming patient transportation initiative and new insight on chronic liver disease
The Danville, Pennsylvania-based system plans to work with rabbittransit to help patients get to their appointments on time. Additionally, researchers from Geisinger and Regeneron Genetics Center recently found a gene variant that's associated with a reduction in the risk for chronic liver disease.
Geisinger CEO discusses telehealth, precision medicine and more
In a recent phone interview, Geisinger President and CEO Dr. David Feinberg chatted about his organization's recent National Symposium, its National Precision Health Initiative and what's on the horizon in 2018.
Geisinger chief innovation officer: 3 areas of healthcare that are ripe for innovation
In a recent phone interview, Geisinger's new chief innovation officer, Karen Murphy, discussed her new role and the future of healthcare transformation.
How to create better drug takers
Although lots of data has been collected to figure out why patients don’t take their medications or don’t take them properly, designing a system to solve that problem that works for every patient equally across a health system has been elusive. One reason is it’s complicated. Merck’s research on the subject highlights some of the […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Geisinger takes part in national diabetes database
Geisinger Health System is one of 11 integrated health systems that has taken part in the largest private sector diabetes database study in the country to develop better ways to prevent people from developing the disease, according to a statement from Kaiser Permanente Center for Health Research. Between them the health systems have 1.1 million […]